About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials | 4,786 Studies Recruiting

Clinical TrialsPancreatic Cancer

Pancreatic Cancer Clinical Trials

Browse 4,786 clinical trials for pancreatic cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2861-2880 of 4,786 trials

RecruitingA Phase II Study of HRS-4642 Combined With AG (Nab-paclitaxel and Gemcitabine) as Conversion Therapy for Locally Advanced Pancreatic CancerThis study will evaluate the effectiveness and safety of HRS-4642 in combination with nab-paclitaxel and gemcitabine (AG regimen) as conversion therapy for patients with locally…NCT07438106·Nanjing CompletedA Study of Irinotecan Liposome in Advanced Pancreatic CancerTo determine the safety and tolerability of irinotecan liposome in combination with oxaliplatin and 5-FU/LV in subjects with advanced pancreatic cancer who have not received prior…NCT04796948·Beijing, Beijing Municipality CompletedEndoTAG-1 / Gemcitabine Combination Therapy to Treat Locally Advanced and/or Metastatic Adenocarcinoma of the PancreasThe intention of this trial is to evaluate safety and efficacy of a combination treatment of EndoTAG-1 with Gemcitabine versus Gemcitabine monotherapy.NCT00377936·Prague and 2 others TerminatedCyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial CancerRATIONALE: Drugs used in chemotherapy, such as cyclophosphamide, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from…NCT00499733·Baltimore, Maryland

Related Searches

pancreas cancertrials

Data from ClinicalTrials.govTerms

Not yet recruitingSpanish Registry of Direct Cholangiopancreatoscopy by Single OperatorEndoscopic ultrasound (EUS) and endoscopic retrograde cholangiopancreatography (ERCP) remain fundamental tools for the diagnosis and treatment of many pancreatobiliary diseases.NCT07064447

CompletedFeasibility of Radiotherapy and Concomitant Gemcitabine and Oxaliplatin in Locally Advanced Pancreatic Cancer and Distal CholangiocarcinomaThe aim of the study is to evaluate the feasibility defined as overall tolerance and toxicity as well as relative dose-intensity and cumulative dose delivered, of an association…NCT00286013·Brussels and 3 others

CompletedPancreatic Cancer Collaborative RegistryRATIONALE: Gathering information about patients with cancer may help doctors learn more about the disease and plan early diagnosis and treatment.NCT00661882·Omaha, Nebraska

TerminatedA Phase I/Expansion Study of DasatinibThe purpose of this study is to find the highest dose of the drugs gemcitabine and dasatinib that can be given for the treatment of pancreatic cancer.NCT00598091·Chapel Hill, North Carolina and 2 others

RecruitingCAR-NK Cells (CL-NK-001) in Pancreatic CancerThis is a single-center, open-label, first-in-human, dose-escalation study in patients with pancreatic cancer.NCT06816823·Shanghai

UnknownThe Therapeutic Evaluation(Both Short-term and Long-term Outcome) of Minimal Invasive Radical Antegrade Modular Pancreatosplenectomy for Left-sided Pancreatic Cancer PatientsPancreatic cancer is regarded as "the king of cancer". It is extremely malignant, with a low sensibility to chemotherapy and radiotherapy, and a poor prognosis.NCT03770559·Beijing

TerminatedStudy of Pasireotide in Patients With Rare Tumors of Neuroendocrine OriginThis study will assess the effectiveness and safety of pasireotide long-acting release in patients who have rare tumors of neuroendocrine origin.NCT00958841·Los Angeles, California and 41 others

TerminatedParicalcitol Plus Gemcitabine and Nab-paclitaxel in Metastatic Pancreatic CancerThis research study is a two stage study which consists of a safety run-in phase and a randomized phase 2 study which include subjects with previously-untreated, metastatic…NCT03520790·Boston, Massachusetts and 1 other

TerminatedComparing Parenteral Nutrition vs Best Supportive Nutritional Care in Patients With Pancreatic CancerA randomised multicentre clinical phase IIIb trial for patients suffering from pancreatic adenocarcinoma receiving defined second or higher line chemotherapy and additionally…NCT01362582·Bad Soden and 3 others

RecruitingNKG2D/CLDN18.21 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid TumorThis is a Phase 1, single-arm, single-center, open-label study to evaluate the safety and effectiveness of NKG2D/CLDN18.2-based CAR-T cells infusion in the treatment of advanced…NCT06134960·Beijing, Beijing Municipality

RecruitingNeutrophil-to-lymphocyte Ratio and CA 19.9 as Predictors of Perineural Invasion in Pancreatic CancerPancreatic cancer has an incidence of 1,401,450 new cases diagnosed annually worldwide and is the third leading cause of cancer-related death in Spain.NCT06747481·Las Palmas de Gran Canaria, Las Palmas

Active not recruiting1911GCCC: Galeterone With Gemcitabine for Patients With Metastatic Pancreatic AdenocarcinomaAssess the effectiveness of galeterone in advanced pancreatic adenocarcinomaNCT04098081·Baltimore, Maryland

CompletedPANFIRE Study: Irreversible Electroporation (IRE) to Treat Locally Advanced Pancreatic CarcinomaIrreversible electroporation (IRE) is a new, minimal-invasive image-guided treatment method for tumors not amenable for surgical resection or thermal ablation, due to vicinity…NCT01939665·Amsterdam, North Holland

CompletedA Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies* To evaluate the safety and tolerability of escalating doses of ERAS-007 in combination with other cancer therapies in study participants with advanced GI malignancies.NCT05039177·Birmingham, Alabama and 13 others

Active not recruitingmFOLFIRINOX With or Without Stereotactic Body Radiotherapy in Locally Advanced Pancreatic AdenocarcinomaModified FOLFIRINOX (mFOLFIRINOX) is the standard of care for patients with locally advanced pancreatic adenocarcinoma.NCT04986930·Seoul

Active not recruitingStereotactic PAncreatic RadioTherapy Adjuvant TherapyWhile surgery is considered the only potentially curative therapy for pancreatic cancer, 5-year overall survival (OS) is typically \<25%.NCT05043857·Rozzano, MI

PreviousPage 144 of 240Next